Lack of response to midostaurin in a patient with vulvar melanoma harboring an unusual KIT D816Y mutation that emerged after a previous treatment with imatinib
Saved in:
| Main Authors: | Antoine Braud, Erwan Pencreach, Dan Lipsker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-01-01
|
| Series: | EJC Skin Cancer |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772611823000095 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MASTOCITOSE SISTÊMICA COM MUTAÇÃO C-KIT EXON 17 (D816V): RELATO DE CASO
by: FF Camargo, et al.
Published: (2024-10-01) -
A Rare Case of Midostaurin-Associated Sweet’s Syndrome
by: Hesham Yasin, et al.
Published: (2022-01-01) -
Digital polymerase chain reaction enhances analysis of the cKIT D816V mutation in systemic mastocytosis patients: Clinical insights
by: Alexandre Eiji Kayano, et al.
Published: (2025-07-01) -
Significance of KIT and PDGFRA mutations in gastric gist imatinib - naive surgically treated patients
by: Ebrahimi Keramatollah, et al.
Published: (2019-01-01) -
SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation
by: Liangying Zhang, et al.
Published: (2025-02-01)